Special Considerations in the Management of HIV-Infected Patients From Minority Communities
Summary
- GRACE trial was a single-arm study of darunavir/ritonavir plus an investigator-selected optimized background regimen in treatment-experienced minorities and women[Smith 2012]
- Study population included 264 black patients, 96 Latinos, and 65 whites
- Black patients typically had more advanced disease at study entry and lower adherence on study treatment
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content